You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nivolumab (OPDIVO®)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Trial (ABP 206, FDA-licensed Nivolumab, EU-authorized Nivolumab)

Not yet recruiting
  • Melanoma
  • ABP 206
  • +2 more
  • (no location specified)
Jun 8, 2023

Pediatric Cancer Trial (Nivolumab)

Approved for marketing
  • Pediatric Cancer
  • Nivolumab
  • (no location specified)
Nov 17, 2021

Melanoma Trial (ABP 206, Nivolumab)

Not yet recruiting
  • Melanoma
  • (no location specified)
Sep 20, 2023

Squamous Cell Carcinoma of the Head and Neck Trial in Pittsburgh (Nivolumab+Relatlimab, Nivolumab+Ipilimumab)

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 13, 2022

Esophageal Squamous Cell Carcinoma Trial (LY01015, Fluorouracil, Cisplatin)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • (no location specified)
Aug 28, 2023

Ovarian Cancer Trial in Boston (drug, biological, procedure)

Recruiting
  • Ovarian Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jul 11, 2022

Follicular Lymphoma Trial in Australia (Opdivo)

Active, not recruiting
  • Follicular Lymphoma
  • Ballarat, Victoria, Australia
  • +4 more
Jan 30, 2023

NSCLC Trial in Durham (Nivolumab, Ipilimumab, Paclitaxel)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Durham, North Carolina
    Duke University Medical Center
Apr 22, 2022

Melanoma, Metastatic Melanoma Trial in Boston (CDX-301, NEOVAX, Nivolumab)

Recruiting
  • Melanoma
  • Metastatic Melanoma
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 12, 2023

Colon Carcinoma Trial in Netherlands (Nivolumab, Ipilimumab, Celecoxib 200mg)

Recruiting
  • Colon Carcinoma
  • Amsterdam, Netherlands
  • +5 more
Jan 23, 2023

Tumors, Carcinoma, Squamous, Antineoplastic Agents Trial (Nivolumab Injection [Opdivo])

Not yet recruiting
  • Neoplasms
  • +2 more
  • Nivolumab Injection [Opdivo]
  • (no location specified)
Jul 19, 2023

Breast Cancer Trial in Boston, Pittsburgh, Dallas (Nivolumab, Ipilimumab)

Active, not recruiting
Has Results
  • Breast Cancer
  • Boston, Massachusetts
  • +2 more
Oct 21, 2022

Metastatic Renal Cell Carcinoma Trial in Cleveland (Nivolumab, Ipilimumab)

Active, not recruiting
  • Metastatic Renal Cell Carcinoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jan 25, 2023

Squamous Cell Carcinoma of Head and Neck Trial (Combination 5-azacytidine and nivolumab, 5-azacytidine, Nivolumab)

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Combination 5-azacytidine and nivolumab
  • +2 more
  • (no location specified)
Dec 7, 2022

Renal Cell Carcinoma Trial in Houston (Tivozanib, Nivolumab)

Not yet recruiting
  • Renal Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Sep 19, 2023

Prostate Cancer, Prostate Disease Trial in Tampa (Nivolumab, Brachytherapy, External Beam Radiation Therapy)

Recruiting
  • Prostate Cancer
  • Prostate Disease
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 11, 2022

Metastatic Gastric Cancer, PD-L1 Gene Amplification, FGFR2 Amplification Trial in New York (Nivolumab, Capecitabine,

Recruiting
  • Metastatic Gastric Cancer
  • +2 more
  • New York, New York
    Bureau for Cancer Research
May 10, 2023

Relapsed or Advanced Gastric Adenocarcinoma, Gastro-esophageal Junction Cancer Trial in Seoul (autologous activated T

Recruiting
  • Relapsed or Advanced Gastric Adenocarcinoma
  • Gastro-esophageal Junction Cancer
  • autologous activated T lymphocyte
  • Seoul, Korea, Republic of
    Gangnam Severacen Hospital
Sep 15, 2021

Hepatocellular Carcinoma Trial in Philadelphia (Abemaciclib, Nivolumab)

Terminated
Has Results
  • Hepatocellular Carcinoma
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Nov 17, 2022

Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma, Stage IV Nasopharyngeal Carcinoma AJCC v8 Trial

Not yet recruiting
  • Metastatic Nasopharyngeal Carcinoma
  • +2 more
  • Nivolumab
  • +5 more
  • (no location specified)
Aug 21, 2023

Melanoma, Urothelial Carcinoma Trial in Berlin (Nivolumab/rHuPH20, Nivolumab)

Not yet recruiting
  • Melanoma
  • Urothelial Carcinoma
  • Berlin, Germany
    Local Institution - 0001
Aug 9, 2022

Advanced Glioblastoma, Metastatic Melanoma in the CNS, MGMT-Unmethylated Glioblastoma Trial in Ramat Gan (Crizanlizumab-Tmca 10

Not yet recruiting
  • Advanced Glioblastoma
  • +2 more
  • Crizanlizumab-Tmca 10 MG/1 ML Intravenous Solution [ADAKVEO]
  • Nivolumab 10 MG/1 ML Intravenous Solution [OPDIVO]
  • Ramat Gan, Israel
    Sheba medical center
Jun 11, 2023

Metastatic Clear Cell Renal Cell Carcinoma Trial in Dallas (Nivolumab, SAbR)

Terminated
Has Results
  • Metastatic Clear Cell Renal Cell Carcinoma
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Jul 12, 2022

Endometrial Tumors, Endometrial Cancer Trial in Seoul (Nivolumab)

Not yet recruiting
  • Endometrial Neoplasms
  • Endometrial Cancer
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System
Mar 21, 2023

Hodgkin Lymphoma Trial in Salt Lake City (Axatilimab, Nivolumab)

Not yet recruiting
  • Hodgkin Lymphoma
  • Salt Lake City, Utah
    Huntsman Cancer Institute at the University of Utah
Feb 1, 2023